Restrictive Covenants In California After Ixchel Pharma
The U.S. Court of Appeals for the Ninth Circuit in Ixchel Pharma v. Biogen recently certified to the California Supreme Court the question whether Section 16600 of the California Business and...To view the full article, register now.
Already a subscriber? Click here to view full article